Cargando…

Response to treatment with intravitreal anti-vascular endothelial growth factors in bilateral exudative cuticular drusen

PURPOSE: To present the response to treatment with anti-vascular endothelial growth factor (VEGF) agents of exudative cuticular drusen (CD) in a patient who developed temporary suspended scattering particles in motion (SSPiM) after injection in the symptomatic eye and full recovery of subretinal hyp...

Descripción completa

Detalles Bibliográficos
Autor principal:	Durlu, Yusuf K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105615/ https://www.ncbi.nlm.nih.gov/pubmed/33997473 http://dx.doi.org/10.1016/j.ajoc.2021.101110

Ejemplares similares

Localised relative scotoma in cuticular drusen
por: Charng, Jason, et al.
Publicado: (2022)

Evaluation of the microperimetry in eyes with cuticular drusen
por: Nam, Seung Wan, et al.
Publicado: (2022)

Retinal Angiomatous Proliferation in an Eye with Cuticular Drusen
por: Sato, Atsuko, et al.
Publicado: (2015)

Clinical manifestations of cuticular drusen in Korean patients
por: Shin, Dong Hoon, et al.
Publicado: (2020)

Clinical Manifestations of Cuticular Drusen: Current Perspectives
por: Fragiotta, Serena, et al.
Publicado: (2021)

Long-Term Resolution of Perifoveal Exudative Vascular Anomalous Complex after Intravitreal Injections of Anti-Vascular Endothelial Growth Factor
por: Torrell-Belzach, Nuria, et al.
Publicado: (2022)

The Development of Suspended Scattering Particles in Motion in a Patient with Exudative Reticular Pseudodrusen
por: Durlu, Yusuf Kemal
Publicado: (2023)

Safety of bilateral same-day intravitreal injections of anti-vascular endothelial growth factor agents
por: Ruão, Miguel, et al.
Publicado: (2017)

Intravitreal Anti-vascular Endothelial Growth Factor for Typical Exudative Age-related Macular Degeneration in Eyes with Good Baseline Visual Acuity
por: Chang, Young Suk, et al.
Publicado: (2014)

Long-term follow-up of perifoveal exudative vascular anomalous complex treated with intravitreal injections of anti-vascular endothelial growth factor and thermal laser photocoagulation
por: Corvi, Federico, et al.
Publicado: (2020)

Serum Concentration of Vascular Endothelial Growth Factor after Bilateral Intravitreal Injection of Bevacizumab
por: Wang, Donghyun, et al.
Publicado: (2014)

Cuticular drusen associated with aneurysmal type 1 neovascularization (polypoidal choroidal vasculopathy)
por: Fragiotta, Serena, et al.
Publicado: (2018)

Age-related macular degeneration eyes presenting with cuticular drusen and reticular pseudodrusen
por: Yoon, Je Moon, et al.
Publicado: (2022)

Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Retinal Disorders
por: Hang, Abraham, et al.
Publicado: (2023)

Aggravation of retinal hard exudates after intravitreal anti-vascular endothelial growth factor therapy for cystoid macular edema and the risk factors: a retrospective study
por: Shi, Rui, et al.
Publicado: (2022)

Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration
por: Davis, R Prince, et al.
Publicado: (2010)

Pseudoflow with OCT Angiography in Eyes with Hard Exudates and Macular Drusen
por: Hou, Kirk K., et al.
Publicado: (2019)

Association between Obstetric Complications and Intravitreal Anti-Vascular Endothelial Growth Factor Agents or Intravitreal Corticosteroids
por: Ben Ghezala, Inès, et al.
Publicado: (2022)

Association analysis of genetic and environmental risk factors in the cuticular drusen subtype of age-related macular degeneration
por: van de Ven, Johannes P.H., et al.
Publicado: (2012)

Whole Exome Sequencing in Patients with the Cuticular Drusen Subtype of Age-Related Macular Degeneration
por: Duvvari, Maheswara R., et al.
Publicado: (2016)

Cuticular drusen presenting with central serous chorioretinopathy in both eyes: A case report
por: Hosoda, Shuhei, et al.
Publicado: (2022)

Systemic Outcomes of Intravitreal Injections of Dexamethasone and Anti-Vascular Endothelial Growth Factor
por: Lin, Tzu-Yi, et al.
Publicado: (2023)

Bilateral choroidal neovascularization associated with optic nerve head drusen treated by antivascular endothelial growth factor therapy
por: Delas, Barbara, et al.
Publicado: (2012)

Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy
por: Yoon, Jihyun, et al.
Publicado: (2021)

Presumed Pyogenic Granuloma Associated with Intravitreal Anti-Vascular Endothelial Growth Factor Therapy
por: Jung, Jesse J, et al.
Publicado: (2011)

Intravitreal Anti Vascular Endothelial Growth Factor Agents in The Management of Retinal Diseases: An Audit
por: Fiebai, Bassey, et al.
Publicado: (2017)

Results of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Inflammatory Choroidal Neovascularization
por: Zina, Sourour, et al.
Publicado: (2021)

Staphylococcus lugdunensis Endophthalmitis Following Intravitreal Anti-vascular Endothelial Growth Factor Injections
por: Ahmed, Umar, et al.
Publicado: (2022)

Profile of Patients Treated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections in Bhutan
por: Rai, Bhim Bahadur, et al.
Publicado: (2023)

Effect of repeated intravitreal anti-vascular endothelial growth factor drugs on corneal nerves
por: Qi, Yuanyuan, et al.
Publicado: (2023)

Progression of retinal vascularization after intravitreal anti-vascular-endothelial growth factor therapy in retinopathy of prematurity
por: Mirghorbani, Masoud, et al.
Publicado: (2022)

Comparative Study of Vascular Endothelial Growth Factor in Exudative and Transudative Pleural Effusion
por: Mohammadzadeh Lari, Shahrzad, et al.
Publicado: (2022)

Analysis of rare variants in the CFH gene in patients with the cuticular drusen subtype of age-related macular degeneration
por: Duvvari, Maheswara R., et al.
Publicado: (2015)

Intravitreal Anti-Vascular Endothelial Growth Factor Agents for the Treatment of Diabetic Retinopathy: A Review of the Literature
por: Chatziralli, Irini, et al.
Publicado: (2021)

Rapid resolution of severe exudation in uveal effusion syndrome with anti-vascular endothelial growth factor alone in a case of bilateral nanophthalmos: a case report
por: Song, Li, et al.
Publicado: (2021)

INTRAVITREAL RANIBIZUMAB TREATMENT FOR ADVANCED FAMILIAL EXUDATIVE VITREORETINOPATHY WITH HIGH VASCULAR ACTIVITY
por: Lyu, Jiao, et al.
Publicado: (2021)

Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents for Ocular Vascular Diseases: Clinical Practice Guideline
por: Nikkhah, Homayoun, et al.
Publicado: (2018)

Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of coats' disease in children
por: Kaul, Shalini, et al.
Publicado: (2010)

Intravitreal Bevacizumab as Anti-Vascular Endothelial Growth Factor in the Management of Complications of Proliferative Diabetic Retinopathy
por: Fernando Arevalo, J.
Publicado: (2013)

Incidence of Endophthalmitis after Intravitreal Anti-vascular Endothelial Growth Factor: Experience in Saudi Arabia
por: Al-Rashaed, Saba, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6tejgmslrp65oju2i4p71d60rf